Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,270.00 | |
50 mg | 10-14 weeks | $ 2,980.00 | |
100 mg | 10-14 weeks | $ 4,000.00 |
Description | PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor. |
Synonyms | PF 06439015, PF-06439015, PF06439015 |
Molecular Weight | 470.52 |
Formula | C22H23FN6O3S |
CAS No. | 1549629-82-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-06439015 mesylate 1549629-82-4 PF-06439015 Mesylate PF 06439015 PF-06439015 PF06439015 Mesylate PF06439015 mesylate PF 06439015 mesylate PF 06439015 Mesylate PF06439015 inhibitor inhibit